Retrograde Open Mesenteric Stenting: A Case Report and Literature Review

Suren Jeevaratnam , Houssam Farres , Camilo Polania-Sandoval , Yetzali Claudio-Medina , Hennessy Morales-Arroyo , Young Erben
{"title":"Retrograde Open Mesenteric Stenting: A Case Report and Literature Review","authors":"Suren Jeevaratnam ,&nbsp;Houssam Farres ,&nbsp;Camilo Polania-Sandoval ,&nbsp;Yetzali Claudio-Medina ,&nbsp;Hennessy Morales-Arroyo ,&nbsp;Young Erben","doi":"10.1016/j.avsurg.2024.100319","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Retrograde open mesenteric stenting (ROMS) is an alternative to mesenteric bypass/antegrade angioplasty and stenting in patients with acute and chronic mesenteric ischemia. We present a case and literature review utilizing ROMS in a patient with severe vascular occlusive disease to treat her superior mesenteric artery (SMA) stenosis.</p></div><div><h3>Case report</h3><p>A 63-year-old woman with a history of severe vascular occlusive disease and previous extensive surgical interventions required ROMS due to SMA stenosis for acute on chronic mesenteric ischemia. There were no in-hospital complications. We also performed a review of the literature to assess the technical success and clinical outcomes of ROMS.</p></div><div><h3>Results</h3><p>A total of six articles with 210 patients (92 males, 118 females) were included. In the studies where the celiac artery and SMA were implicated, technical success was 92.9%, conversion to bypass was 4.3%, and 30-day mortality was 29.5%. In the studies where only the SMA was implicated, technical success was 90.7%, conversion to bypass was 7.2%, and 30-day mortality was 23.7%. In cases of acute mesenteric ischemia, the 30-day mortality rate was 34.2%.</p></div><div><h3>Conclusion</h3><p>Though open surgical bypass and antegrade endovascular angioplasty and stenting have been the first-line treatment options for mesenteric ischemia, ROMS is an excellent alternative option with a high technical success rate that can be utilized when conventional treatment modalities are not technically feasible or in the setting of concomitant open abdominal exploration for the assessment of bowel ischemia.</p></div>","PeriodicalId":72235,"journal":{"name":"Annals of vascular surgery. Brief reports and innovations","volume":"4 3","pages":"Article 100319"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772687824000710/pdfft?md5=9d7e82bc89ccce300b06fad204b1d303&pid=1-s2.0-S2772687824000710-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of vascular surgery. Brief reports and innovations","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772687824000710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Retrograde open mesenteric stenting (ROMS) is an alternative to mesenteric bypass/antegrade angioplasty and stenting in patients with acute and chronic mesenteric ischemia. We present a case and literature review utilizing ROMS in a patient with severe vascular occlusive disease to treat her superior mesenteric artery (SMA) stenosis.

Case report

A 63-year-old woman with a history of severe vascular occlusive disease and previous extensive surgical interventions required ROMS due to SMA stenosis for acute on chronic mesenteric ischemia. There were no in-hospital complications. We also performed a review of the literature to assess the technical success and clinical outcomes of ROMS.

Results

A total of six articles with 210 patients (92 males, 118 females) were included. In the studies where the celiac artery and SMA were implicated, technical success was 92.9%, conversion to bypass was 4.3%, and 30-day mortality was 29.5%. In the studies where only the SMA was implicated, technical success was 90.7%, conversion to bypass was 7.2%, and 30-day mortality was 23.7%. In cases of acute mesenteric ischemia, the 30-day mortality rate was 34.2%.

Conclusion

Though open surgical bypass and antegrade endovascular angioplasty and stenting have been the first-line treatment options for mesenteric ischemia, ROMS is an excellent alternative option with a high technical success rate that can be utilized when conventional treatment modalities are not technically feasible or in the setting of concomitant open abdominal exploration for the assessment of bowel ischemia.

逆行开放式肠系膜支架置入术:病例报告与文献综述
目的逆行开放式肠系膜支架植入术(ROMS)是肠系膜搭桥术/逆行血管成形术和支架植入术的替代方法,适用于急慢性肠系膜缺血患者。病例报告:一名 63 岁的女性患者患有严重的血管闭塞性疾病,既往曾接受过大量外科手术治疗,因 SMA 狭窄而需要采用 ROMS 手术治疗急性和慢性肠系膜缺血。院内无并发症。我们还对文献进行了回顾,以评估 ROMS 的技术成功率和临床效果。在涉及腹腔动脉和 SMA 的研究中,技术成功率为 92.9%,转为搭桥的比例为 4.3%,30 天死亡率为 29.5%。在仅涉及 SMA 的研究中,技术成功率为 90.7%,转为搭桥的比例为 7.2%,30 天死亡率为 23.7%。结论虽然开放手术搭桥和前向血管内成形术及支架植入术一直是肠系膜缺血的一线治疗方案,但 ROMS 是一种技术成功率高的极佳替代方案,在传统治疗方法技术上不可行或同时进行开腹探查以评估肠缺血的情况下可以使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
0
审稿时长
62 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信